Literature DB >> 2412437

Postoperative elevation of serum pancreatic secretory trypsin inhibitor.

K Matsuda, M Ogawa, T Shibata, S Nishibe, K Miyauchi, Y Matsuda, T Mori.   

Abstract

Postoperative transient elevations of serum pancreatic secretory trypsin inhibitor are reported for the first time. The elevations were independent of the surgical procedures or sites, and the maximum serum pancreatic secretory trypsin inhibitor was seen on the 2nd to 4th postoperative day. The elevation of pancreatic secretory trypsin inhibitor was significantly correlated with the length of the operation time and the volume of blood loss during the operation. The change of serum pancreatic secretory trypsin inhibitor was also significantly correlated with those of white blood cell count, alpha 1-antitrypsin, and fibrinogen.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412437

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

Review 1.  Granzyme A activates another way to die.

Authors:  Judy Lieberman
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Immunoreactive pancreatic secretory trypsin inhibitor in normal, inflammatory and neoplastic gallbladders.

Authors:  H Bohe; M Bohe; C Lindström; K Ohlsson
Journal:  Gastroenterol Jpn       Date:  1991-02

3.  Production and secretion of pancreatic secretory trypsin inhibitor in normal human small intestine.

Authors:  H Bohe; M Bohe; E Lundberg; A Polling; K Ohlsson
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

Review 4.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

5.  Reaction of a tumour-associated trypsin inhibitor with serine proteinases associated with coagulation and tumour invasion.

Authors:  U Turpeinen; E Koivunen; U H Stenman
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

6.  Varying occurrence of gastroduodenal immunoreactive pancreatic secretory trypsin inhibitor.

Authors:  M Bohe; C G Lindström; K Ohlsson
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

7.  Purification and identification of a binding protein for pancreatic secretory trypsin inhibitor: a novel role of the inhibitor as an anti-granzyme A.

Authors:  Satoshi Tsuzuki; Yoshimasa Kokado; Shigeki Satomi; Yoshie Yamasaki; Hirofumi Hirayasu; Toshihiko Iwanaga; Tohru Fushiki
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

8.  Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.

Authors:  Alexander Gaber; Björn Nodin; Kristina Hotakainen; Elise Nilsson; Ulf-Håkan Stenman; Anders Bjartell; Helgi Birgisson; Karin Jirström
Journal:  BMC Cancer       Date:  2010-09-17       Impact factor: 4.430

9.  Pancreatic secretory trypsin inhibitor in human Brunner's glands.

Authors:  H Bohe; M Bohe; C Lindström; K Ohlsson
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

10.  A novel discriminant score based on tumor-associated trypsin inhibitor for accurate diagnosis of metastasis in patients with breast cancer.

Authors:  Hatem A El-mezayen; Fatheya M Metwally; Hossam Darwish
Journal:  Tumour Biol       Date:  2013-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.